Aqara Introduces Partners Program to Support Smart Home Installers in Growing Business
19.10.2021 16:00:00 EEST | Business Wire | Press release
Aqara, a leading provider of smart home products, announced the launch of its Professional Partners Program for smart home installers and integrators. Utilizing Aqara’s decade-long experience in the smart home industry and its comprehensive suite of smart home products, advanced technologies, solutions, and tools, the Professional Partners Program aims to support professional installers in enhancing their service offerings and growing their businesses. The Program also welcomes the broader professional community, such as shading control installers, smart lock locksmiths, home theater installers, interior designers and electricians, to join the Aqara partner network.
With years of experience in offering high-quality products to global consumers, Aqara now seeks to join forces with the professional community to boost adoption of the smart home technology worldwide. As part of Aqara Partners Program, participants will enjoy:
- Priority access to new Aqara products
- Special promotional pricing on certain products
- Comprehensive product training support and resources
- Opportunity to connect with interested Aqara users in local areas
- Marketing support
Starting in October 2021, Aqara has launched an exclusive Smart Roller Shade Controller Package as the first promotional event within the Professional Partners Program for a limited time. The Smart Roller Shade Controller is the global version of Aqara’s most popular roller shade motor, which is designed to automate a variety of roller blinds and even projector screens. Bound with an Aqara hub, the controller allows roller shades to be controlled by mobiles, voice commands (Apple Siri, Google Assistant, Yandex Alice, Naver Clova, etc.), pre-set schedules, and via home automations in which roller shades could be triggered by illumination condition, human motion, room temperature, etc.
To learn more about the Professional Partners Program or register for the Smart Roller Shade Controller Package, please visit our website.
About Aqara
Founded in 2016, Aqara is a leading smart home provider with offices in New York and Shenzhen. The Company provides comprehensive smart home products and solutions that are beautifully designed, long-lasting, and easy to use. Products range from a variety of smart sensors to switches, curtain controllers, and smart door locks. Over the last few years, Aqara has opened more than 600 Aqara stores to provide more personalized smart home solutions for individual households and businesses.
Aqara currently serves more than 2 million customers worldwide, with distribution partners in the United States, EU, Russia, Southeast Asia, Korea, and China. The Company also offers one of the most comprehensive suite of HomeKit compatible smart home solutions in the market, and its products can also be found in Apple Stores across Europe and Asia. As the Company continues to expand its global footprint, Aqara hopes to bring more accessible, smart home technology to households around the world.
For more information, please visit our website and follow our social platforms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211019005028/en/
Contact information
Michell Li
Email:media@aqara.com
Phone number: 8618501199430
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 09:49:00 EEST | Press release
Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FDA validated Brenus Pharma's advanced regulatory and manufacturing capabilities. This operational readiness will accelerate patient access and data generation across both European and US sites for a Phase II program planned for 2027. "FDA's acceptance of our IND represents a major validation of our program and enables the full execution of our clinical strategy across Europe and the United States. Achieving regulatory alignment across multiple jurisdictions refl
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 09:00:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare and specialty care where there is significant unmet patient need, presented positive results from the OLINGUITO Phase 3 clinical trial (NCT05785611iEudraCT 2022-501354-10-01ii) at EULAR 2026. In OLINGUITO filgotinib, an oral, once-daily JAK1 preferential inhibitor under investigation for the treatment of adult patients with active axial spondyloarthritis (axSpA), demonstrated sustained improvements in the signs and symptoms of axSpA, including disease activity and inflammation.iii Safety was consistent with the known profile of filgotinib, indicating a favourable benefit-risk profile for patients with active axSpA.iii The OLINGUITO trial consists of two international, randomised, double-blind, placebo-controlled studies (Study A and Study B), evaluating the efficacy and safety of filgotinib 200mg once-daily vs. placebo in patients with an established diagnosis of axSpA as per ASAS classification.i Eligi
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 09:00:00 EEST | Press release
Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to digital to manage their businesses. In late 2025, Tide received a strategic investment from TPG, a leading global alternative asset manager, valuing the company at $1.5 billion. Oliver Prill, CEO of Tide, said: “We are delighted to be crossing the 2 million member milestone. This number is a testament to the trust that our members place in us in all our markets. Behind every
Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 01:00:00 EEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm
SLB Announces Date for Second-Quarter 2026 Results Conference Call26.5.2026 20:00:00 EEST | Press release
SLB (NYSE: SLB) will hold a conference call on July 24, 2026, to discuss the results for the second quarter ending June 30, 2026. The conference call is scheduled to begin at 9:30 a.m. U.S. Eastern time and a press release regarding the results will be issued at 7:00 a.m. U.S. Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 715-9871 within North America or +1 (646) 307-1963 outside of North America approximately 10 minutes prior to the start of the call and the access code is 3440360. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/157027565 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until July 31, 2026, and can be accessed by dialing +1 (800) 770-2030 within North America or +1
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom